Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle┬«) technology, today announced…

Financing or Leasing a Car

With prices today, you might consider financing or leasing your next car. If you do, here are some things to keep in mind. ┬á BEFORE YOU BUY OR LEASE A…

Healthcare Financing and Medical Credit Card

We are here to support you. However, to help limit the spread of the virus, we have reduced the number of our employees in our phone contact centers. It is…